Clinical Trial Update: Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial updating the combination of recombinant human endostatin with Envafolimab and Synchronal radiochemotherapy in locally advanced squamous non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Envafolimab (envafolimab)
• Recombinant human endostatin (recombinant human endostatin)
• Synchronal radiochemotherapy

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Locally Advanced Squamous Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN